A success story coming from IGBMC research, beating national records
July 6, 2018
Created in mid-2016, the Alsatian startup Dynacure, specialising in the treatment of rare neuromuscular diseases, has just announced a historic fund-raising of €47 million, which puts it among the French records in this field. This success is based on the scientific excellence of the IGBMC (CNRS/INSERM/UNISTRA), one of the most important biomedical research institutes in Europe. It is also the result of a major mobilisation by SATT(2) Conectus, the investment fund Kurma Partners and the Californian biopharma Ionis Pharmaceuticals.